This journal article is a practice guideline that provides recommendations summarizing the growing literature and current best practices of chronic Hepatitis C Virus (HCV) treatment, including treatment in difficult-to-treat populations. These recommendations are based on an extensive review of published data, national consensus recommendations, and input from thought leaders involved in HCV care and treatment.
This report, for health professionals, government agencies, and organizations, presents information about HIV/AIDS and TB. It provides epidemiological statistics concerning the relationship between HIV/AIDS and TB, including incidence, morbidity rates, and mortality rates. It discusses TB and HIV transmission, how HIV can facilitate the development of active TB, and recommendations for the prevention of TB among HIV-positive persons.
This report summarizes potential uses of nucleic acid amplification (NAA) tests such as the Amplified Mycobacterium Tuberculosis Direct Test (MTD) for TB diagnosis and provides interim guidelines for the use of such tests. The report lists the current NAA tests, their FDA approved uses, their non-approved indications also known as off-label uses, limitations, and cautions.
This report summarizes findings of the epidemiologic study conducted by health departments in the four US states bordering Mexico (Arizona, California, New Mexico, and Texas) to characterize patterns of immigration and migration among foreign-born Hispanic patients with TB and their behaviors in seeking health care. The 181 consenting Hispanic patients under treatment for TB during October 1, 1995 to January 5, 1996, completed a standardized questionnaire and additional data were obtained from medical charts and laboratory reports.
This report describes approaches for managing patients with TB who are candidates for or who are undergoing protease inhibitor therapy and presents interim recommendations for managing these patients until additional data are available and formal guidelines are issued. Protease inhibitors interact with rifamycin derivatives, which are used to treat and prevent the mycobacterial infections commonly observed in patients with the HIV. The report provides background information on the management of TB and the three treatment options currently available for these patients.
This report summarizes CDC and State health departments investigations and provides guidance about notification of passengers and flight crew after exposure to TB during travel on commercial aircrafts. From January 1993 through February 1995, CDC and State health departments completed an investigation of six instances in which passengers or flight crew traveled on commercial aircraft while infectious with TB.
This report discusses the attempts by two states, New York and South Carolina, to improve patient adherence to anti-TB therapy during 1986-1991 using a combination of strategies. Both states used a combination of strategies: incentives, directly observed therapy (DOT), court-ordered DOT, and commitment to a secured, long-term care facility. The report provides recommendations for local and state health departments to increase completion rates of anti-TB therapy.
